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EFFECTS OF PRENATAL GESTATIONAL DIABETES NUTRITION 
EDUCATION CLASS AND INDIVIDUAL FOLLOW-UP ON MATERNAL AND 
INFANT OUTCOMES 
Samantha List, RD, LMNT 
The University of Nebraska Medical Center, 2016 
ABSTRACT 
BACKGROUND: Gestational Diabetes Mellitus (GDM) is defined by glucose 
intolerance detected with the onset of pregnancy, and if gone undetected and untreated, 
can lead to morbidities for the mother and baby. Implementation of nutrition counseling 
can work to reduce the risk of complications through dietary modification promoted and 
adopted during pregnancy. Follow-up is important, as individual assessment is used to 
modify recommendations. GDM class and follow-up provided through the Diabetes 
Center of Nebraska Medicine covers and promotes proper management of blood glucose 
(BG) during pregnancy for women with GDM.  
PURPOSE: The purpose of this study was to assess the impact of GDM class and 
follow-up with a Certified Diabetes Educator (CDE) on maternal and infant outcomes in 
women diagnosed with gestational diabetes as well as to establish rate of individual 
follow-up after GDM class attendance.  
METHODS: A retrospective medical record review was conducted on women with 
GDM who attended GDM class between the dates of July 2014-January 2015. The 
primary maternal outcome was pregnancy weight gain and primary infant outcome was 
lowest blood glucose. Secondary outcomes include mode of delivery, birth weight, 




staff, and need for IV, heart, and respiratory support. An analysis of proportions and 
means, via Fischer’s Exact Test and Mann-Whitney U Test, was preformed, as 
appropriate, on variables between groups: mothers who attended class and follow-up 
verse those who only attended class. Rate of follow-up with a CDE post GDM class was 
also calculated. 
RESULTS: Follow-up rate with a CDE after group class was 67.3%, leaving 32.7% 
without follow-up, which may be linked to increased gravidity of those in the non-follow-
up group (1.3 vs. 2.81, p=0.004). No significant differences in maternal and fetal 
outcomes were identified between groups. 
CONCLUSION:  Findings indicate that group GDM class held at Nebraska Medicine’s 
Diabetes Center, on its own, successfully communicates information to women with 
















Diabetes Mellitus (DM) is a group of metabolic diseases characterized by defects 
in insulin secretion, action, or both resulting in hyperglycemia. One of these diseases, 
Gestational Diabetes Mellitus (GDM), is defined by glucose intolerance detected with the 
onset of pregnancy
1
. If gone undetected and untreated, GDM can lead to significant 
morbidities for the mother and baby, during pregnancy and for the long term
2
. 
Consequences include higher rates of stillbirth, polyhydramios, gestational hypertension, 
macrosomia (birth weight >4000 grams), and caesarean delivery
3
; however, GDM risk 
factors can be reduced with healthy dietary patterns promoted and adopted during 
pregnancy through the implementation of nutrition counseling
4
.  
Medical Nutrition Therapy (MNT) is the initial treatment for gestational diabetes, 
generally characterized by a division of calories and carbohydrate over three meals and 
two to four snacks, however, the diet is individualized to the person throughout follow-
up
5
. Goals of MNT in gestational diabetes include achievement and maintenance of 
normoglycemia, prevention of ketosis, and promotion of appropriate weight gain based 
on maternal pre-pregnancy BMI
6




as appropriate pregnancy weight gain has been associated with improved outcomes
8
.  
Close follow-up is necessary to ensure nutritional adequacy, since individual 
assessment of diet, weight changes, and blood glucose monitoring data is used to modify 
nutrition recommendations. In fact, it is recommended that those with GDM visit a 
registered dietitian (RD) a minimum of three times
9
, as nutrition counseling in this 
population has resulted in reduced saturated fat and caloric intake
10
, decreased pregnancy 
weight gain in obese women
11






. Despite the benefits of and recommendations for nutritional counseling, 
however, it has been shown that nutrition counseling rarely takes place at the 
recommended frequency stated above
13
.  
Gestational Diabetes class and follow-up provided through the Diabetes Center of 
Nebraska Medicine is meant to cover and promote proper management of blood glucose 
during pregnancy in mothers with gestational diabetes. Classes are led by registered 
dietitians who are also certified diabetes educators (CDE), and follow-up appointments 
are administered by either an RD, nurse, or exercise physiologist, who are all certified in 
diabetes education. Education includes an overview of gestational diabetes, blood glucose 
monitoring and goals, nutritional intervention and guidance, benefits and impact of 
exercise, medication management, as applicable, and problem solving. Women who 
attend individual follow-up are then provided with feedback based on blood glucose and 
diet records upon which adjustments are made. In addition, these women are given more 
information on breastfeeding and diabetes screening recommendations post-delivery. The 
results of this study established the previously unknown rate of gestational follow-up 
education at the Nebraska Medicine Diabetes Center, and will be used to evaluate the 
existing gestational diabetes education program as well as directly influence program 









Review of Literature 
GDM – Definition, Diagnostic Criteria, and Prevalence 
Gestational Diabetes Mellitus (GDM), is defined as glucose intolerance detected 
with the onset of pregnancy
1
. Historically, the diagnosis of GDM across countries, based 
on prevention of future onset DM in mothers, was highly variable, causing problems in 
international discussion. Due to this, the International Association of Diabetes and 
Pregnancy Study Groups (IADPSG) announced uniform diagnostic criteria to be used 
worldwide
1
 based on the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) 
study
15
, conducted in 25,505 women in nine different countries to evaluate maternal and 
fetal outcomes.  
The HAPO study found that with increasing blood glucose (BG) levels following 
the 75-gram oral glucose tolerance test (OGTT) between 24-32 weeks of gestation, 
frequency of birth weight >90
th
 percentile, caesarian section, and neonatal hypoglycemia 
increased
15
. When comparing the highest 1-hour plasma glucose category to the lowest, 
infants were more likely to be born at weights greater than the 90
th
 percentile, (OR 4.49, 
95% CI 3.16-6.39), women were more likely to have caesarian deliveries, (OR 1.86, 95% 
CI 1.35-2.57) and infants were at more likely to experience hypoglycemia (OR 1.29, 95% 
CI 0.51-3.31). Results from this study revealed that with elevated blood glucose exposure 
to the fetus during pregnancy, the odds of maternal and fetal outcomes, described above, 
also increased. Since no clear blood glucose level demonstrated an increase in primary 
outcomes
15
, in 2008-2009, the IADPSG revised GDM diagnostic criteria and recommend 
that all women without known diabetes undergo a 75-gram OGTT between 24-28 weeks 




times higher than the lowest category for fasting, 1-hour, and 2-hour plasma blood 




Table 1. Screening and Diagnostic Criteria for Gestational Diabetes Mellitus
1 
Time Frame Diagnostic Criteria 
Fasting Plasma Glucose >92 mg/dL 
1-Hour Plasma Glucose >180 mg/dL 
2-Hour Plasma Glucose >153 mg/dL 
Patients are recommended to fast for a minimum of 8 hours prior to 75-gram OGTT, 
which is to be administered between 24-28 weeks of gestation. To be diagnosed with 




In a recent study involving 2,448 Italian pregnant women, the new IADPSG 
diagnostic criteria (Table 1) were utilized in place of previous screening protocol. As a 
result, 538 more women were screened, 31.8% of which were diagnosed with GDM. This 
new diagnostic criteria required more GDM screening; however, it also identified 171 




Although the ADA has now adopted this new criterion, the Committee on 
Obstetric Practice continues to recommend a two-step approach to screening and 
diagnosis. This process is different, as they recommend pregnant women to first be 
screened with a 50-gram, 1-hour OGTT at 24-28 weeks of gestation and if failed, are 
diagnosed based on the result of a 100-gram, 3-hour OGTT
17
. Although universal 
diagnostic criterion is available, protocols continue to remain variable at this time.  
According to the ADA (2013), about 7% of pregnancies are complicated by 




population studied. Based on these estimations, this amounts to approximately 200,000 
cases of gestational diabetes each year
1
. DeSisto et al. (2014) aimed to provide current 
data on the prevalence of GDM based on birth certificates and the Pregnancy Risk 
Assessment Monitoring System and found that in 2010, prevalence of GDM was as high 
as 9.2% in the United States. This study included records from 23,479 women in 15 states 
and New York City. Additionally, this study group found that prevalence increased with 




Pathophysiology of GDM 
During the first trimester of pregnancy, insulin sensitivity tends to be normal and 
in some cases, greater than normal
18
. As pregnancy proceeds, however, insulin resistance 
becomes more pronounced
19
, and according to Buchanan and colleges (1990), insulin 
sensitivity can be reduced up to 60-80%
20
. Although this phenomenon is multifactorial, it 
can be explained, in part, by increased secretion of progesterone, which decreases 
glucose transport and insulin binding, and hormone placental lactogen, known to reduce 
insulin sensitivity
21
. Additionally, plasma concentration of cortisol doubles during 
pregnancy, which can induce insulin resistance when in excess
22
. In order to meet 
elevated energy needs, endogenous glucose production (EGP) increases by 16-30%
18
. As 
a result of impaired insulin sensitivity, glucose utilization, and EGP suppression, plasma 
glucose levels after meals are higher and last longer in pregnancy. Though these changes 
and mechanisms do occur in normal pregnancies, in cases of gestational diabetes, the 
degree of insulin resistance is much more severe
23
.  




by GDM, insulin secretion increases starting in the first trimester and is maximized by 
the third
24
. To accommodate, the β-cells of the pancreas undergo both functional and 
structural changes
25
 such as growth, proliferation
26
, and increased insulin secretion
27
. 
When these actions are insufficient, abnormal glucose tolerance is observed. In fact, 
Xiang and colleges (1999) estimate a 67% reduction in β-cell compensation in women 
with GDM when compared to those with normal pregnancies
28
.  
Risk Factors and Complications of GDM 
In a study conducted by Griffin et al. (2000), subjects diagnosed with GDM were 
significantly older (31 vs. 27 years, p<0.05) and weighed more (80 vs. 73.8 kg, p<0.05) 
than those not diagnosed although parity was not significantly different
29
.  In addition to 
weight and age, the American Diabetes Association identifies high blood glucose, 
abnormal cholesterol, smoking, inactivity, high blood pressure, and poor diet quality as 
risk factors
30
. The CDC also includes family history of diabetes, having a multiple 
pregnancy, and having GDM in a previous pregnancy as potential causes
31
. In a study 
encompassing over 65,000 pregnancies, those with gestational diabetes in one pregnancy 
had a 41% risk of developing GDM in a second, compared to a 4% risk in those who did 
not have GDM previously
14
.  
GDM has been linked to several adverse maternal and fetal outcomes. As 
described earlier, the HAPO study found that women with GDM are at higher risk of 
caesarian section, and their infants are born at birth weights >90
th
 percentile and 
experience neonatal hypoglycemia in greater frequency
15
. Langer and Mazze (1988) also 
found a relationship between GDM and infant birth weight, demonstrating that as mean 




age (LGA) and macrosomatic infants also increased
32
. Another study focusing on 
pregnant women less than 35 years of age with no previous GDM risk factors, rate of 
caesarian section was significantly more common in women with gestational diabetes 
when compared to those without (OR 2.36, 95% CI 1.53-3.64, p<0.001) and remained 
significant after controlling for age, pre-pregnancy BMI, and parity (OR 1.92, 95% CI 
1.21-3.06, p=0.006). Additionally, more newborns of GDM mothers were born large-for-
gestational-age (OR 3.53, 95% CI 1.34-9.34, p=0.011) and had significantly higher birth 
weights (p<0.001) even after controlling for maternal age, pre-pregnancy BMI, and 
gestational age at birth. Polyhydramnios, the excessive accumulation of amniotic fluid, 
was also associated with GDM (OR 4.48, 95% CI 1.20-16.73, p=0.025) in addition to 
admission to the NICU (OR 4.39, 95% CI 1.44-13.37, p=0.009)
33
.           
GDM - Nutrition Therapy and Patient Outcomes 
Medical Nutrition Therapy (MNT) is the initial treatment for gestational diabetes, 
generally characterized by a division of calories and carbohydrate over three meals and 
two to four snacks; however, specific recommendations should be tailored to the patient 
throughout follow-up
5,38
. Goals of MNT in gestational diabetes include achievement and 
maintenance of normoglycemia, prevention of ketosis, promotion of appropriate 
pregnancy weight gain, based on maternal pre-pregnancy BMI
6,35
, and to support fetal 
growth and wellbeing through adequate nutrition
7
. It is the position of the ADA that all 
women with the diagnosis of GDM should receive nutritional counseling by a Registered 
Dietitian when possible, and individualized MNT is recommended and should include 
counseling on adequate calorie provision, appropriate macronutrient distribution, and 
breastfeeding after delivery
34




study found that 22% of women with gestational diabetes stated they never received 




Supporting adequate weight gain during pregnancy has been shown to improve 
infant and maternal outcomes. In a retrospective study involving 31,074 women during 
the years of 2001-2004, appropriate weight gain throughout pregnancy, per Institute of 
Medicine recommendations
7
, resulted in optimal outcomes while excessive weight gain 
was associated with an increased odds of LGA infants (OR 1.72, 95% CI 1.53-1.93), 
early delivery (OR 1.30, 95% CI 1.14-1.48), and cesarean delivery (OR 1.52, 95% CI 
1.26-1.83). Additionally, those with suboptimal weight gain had greater odds of having 
small-for-gestational age (SGA) infants (OR 1.39, 95% CI 1.01-1.90), but lower odds of 
having LGA infants (OR 0.60, 95% CI 0.52-0.67)
8
. Please see Table 2 below for the 
Institute of Medicine’s most recent weight gain recommendations based on pre-
pregnancy Body Mass Index (BMI)
35
. 
Table 2. Institute of Medicine Gestational Weight Gain Recommendations
35 














Regulating calorie and macronutrient provision also aids in blood glucose 
management. In women with GDM who had BMIs greater than 30 kg/m
2
, a 30-33% 




hyperglycemia and plasma triglycerides without inducing ketonuria, while diets with 
50% reduction in calories (~1,200 calories per day) also minimized hyperglycemia, but 
were associated with an increase in ketonuria
36
. Limiting carbohydrates to 35-40% of 
total daily calories has been shown to reduce maternal BG and improve maternal and 
infant outcomes. In a study conducted on women with diet-controlled GDM, a diet low in 
carbohydrate, composed of less than 42% total calories from carbohydrate, was compared 
to a high carbohydrate diet, with energy from carbohydrates exceeding 45% of total 
calories. While the groups were demographically similar, postprandial BG levels were 
significantly reduced in the low-carbohydrate group (p<0.04) and fewer participants in 
this group required the addition of insulin therapy (p<0.047, RR 0.22; 95% CI 0.02, 1.00) 
when compared to those consuming a high carbohydrate diet. In addition, incidence of 
LGA infants was significantly lower in the low carbohydrate group when compared the 
high-carbohydrate group (p< 0.035, RR 0.22, 95% CI 0.05, 0.91) and required fewer 
caesarian sections (p< 0.037; RR 0.15; 95% CI 0.04, 0.94)
37
.  
Physical Activity and Pharmacological Therapy for GDM 
In addition to diet modification, regular aerobic exercise has also been shown to 
lower fasting and post-meal BG and may be used in addition to nutritional therapy to 
improve maternal BG control. Although the optimal frequency and intensity of exercise 
for lowering maternal BG have not been established, it appears that at least three exercise 
sessions weekly, greater than fifteen minutes each, are necessary to impact maternal BG 








insulin therapy has been shown to reduce fetal complications most consistently
34
. If 
insulin therapy is added to nutrition therapy, it is necessary to maintain consistent 
carbohydrate distribution at meals and snacks to facilitate insulin adjustments
39
. Oral 
glucose agents, such as glyburide, are not currently FDA approved for this population or 
recommended as a method to lower BG in women with GDM; however, one non-blinded 
clinical trial comparing glyburide to insulin therapy yielded similar perinatal outcomes
40
. 
























The institutional review board at the University of Nebraska Medical Center 
(Omaha, NE) approved this study. This is a retrospective medical record review 
conducted on mothers diagnosed with GDM who attended gestational diabetes class at 
the Nebraska Medicine Diabetes Center from July 2014-January 2015 and their infants. 
Classes are led by registered dietitians who are also certified diabetes educators (CDE), 
and follow-up appointments are administered by a registered dietitian, nurse, or exercise 
physiologist, who are all certified in diabetes education. Education includes an overview 
of gestational diabetes, blood glucose monitoring and goals, nutritional intervention and 
guidance, benefits and impact of exercise, problem solving, and medication management, 
as applicable. Women who attend individual follow-up are then provided with feedback 
based on blood glucose and diet records upon which adjustments are made. In addition, 
these women are given more information on breastfeeding and diabetes screening 
recommendations post-delivery. 
This time period was chosen for the consistency of care provided, as there was 
minimal staff turnover, and allowed enough time to pass for mothers who attended class 
to reach delivery. GDM mothers less than 19 years of age, expecting a multiple 
pregnancy, and those scheduled for group class but did not attend were excluded. After 
extensive chart review, 49 mothers and 42 infants were eligible for this study. This 
sample was then split further into follow-up (Group 1) and non-follow-up (Group 2) 
groups, where those who attended GDM class and an individual follow-up appointment 





Clinical outcomes collected via retrospective chart review include: lowest infant 
blood glucose, presence of infant hypoglycemia, infant birth weight, gestational age, 
involvement of neonatal intensive care unit (NICU) staff, maternal pre-pregnancy BMI, 
maternal weight gain, maternal weight gain according to recommended ranges, mode of 
delivery (vaginal vs. caesarian section), average maternal blood glucose, and hemoglobin 
A1c, as available. Other variables collected include: age, ethnicity, race, insurance, and 
zip code, additional complications, serum calcium, method of feeding (formula vs. 
breastfeeding), IV support, and APGAR score of the infants at birth. Presence of infant 
hypoglycemia was defined by blood glucose less than 30 mg/dL and weight gain 
recommendations were based on the Institute of Medicine parameters (see Table 2). 
Health insurance was divided into two groups: public (Medicaid) and private (others).  
Analysis 
Women were separated into two groups: those who attended class in addition to 
one or more follow-up appointments and those who attended GDM group class but did 
not participate in a follow-up appointment. Those who were scheduled for group class but 
did not attend were excluded. Rate of follow-up with a CDE post gestational diabetes 
class was established by calculating proportion. Additionally, an analysis of proportions 
and means, via Fischer’s Exact Test and Mann-Whitney U Test, was preformed, as 
appropriate, on maternal and fetal outcomes between the two groups. Results with a p-
value <0.05 were deemed significant. In order to accept the two hypotheses, results must 
demonstrate significantly improved fetal and maternal outcomes in the follow-up group 





There were 33 mothers and 28 infants in Group 1, the follow-up group, and 16 
mothers and 14 infants in Group 2, the group with no individual follow-up after group 
class. There were no significant differences found in maternal baseline characteristics, 
with the exception of gravidity, in which women in Group 2 had significantly more 
previous pregnancies than women in Group 1. Results are displayed below in Table 1.  
Table 3. Maternal Baseline Characteristics 





 No. Mean SD No. Mean SD P-value 
Age (years) 33 28.36 4.676 16 29.19 6.123 0.474 





33 31.23 7.55 15 37.12 12.84 0.161 
Week of Gestation 32 27.25 6.825 16 30.88 3.704 0.123 
1-Hour GTT 
(mg/dL) 
28 184.86 25.2 11 168.45 34.9 0.318 
3-Hour GTT 
(mg/dL) 
24 127.54 31.12 7 121 31.9 0.620 
HbA1c (%) 8 5.41 0.75 5 5.12 0.58 0.418 
 No. Proportion % No. Proportion % P-value 
Ethnicity 
   Hispanic 





















   White 





















   Public  




















* Significant p-value (p<0.05) 
Gravidity = Number of previous pregnancies 
GA = Gestational Age  
BMI = Body Mass Index 
 
GTT = Glucose Tolerance Test  






From July 2014-January 2015 at the Nebraska Medicine Diabetes Center, 67.3% 
of women who attended GDM group class also came back for follow-up, leaving 32.6% 
of this sample without individual follow-up with a Certified Diabetes Educator after 
group class (Figure 1). 
















Results regarding maternal outcomes are displayed in Table 4, and visual displays 
of maternal blood glucose levels and mode of delivery proportions, between groups, can 
be viewed in Figures 2 and 3, respectively.  
Table 4. Maternal Outcomes 





 No. Mean SD No. Mean SD P-value 
Average Maternal BG 
(mg/dL) 
32 102 10.5 9 100 10.2 0.670 
Maternal Weight Gain 
(lbs) 
26 20.2 17 12 21.5 16.7 0.888 
 No. Proportion %  Proportion % P-value 
Weight Gain within 
Recommended Range 
   Yes 


























Mode of Delivery 
   Vaginal  




















Recommended Weight Gain Based on Institute of Medicine Recommendations
35 
 
No statistical significance was found in average maternal blood glucose between 
groups (p=0.670) and mean maternal weight gain was similar between groups, at 20.2 lbs 
for those with follow-up and 21.5 lbs for those without follow-up (p=0.888). Although 
not statistically significant, 69.23% of women in Group 1 (Follow-Up) experienced 
weight gain within the recommended range per pre-pregnancy BMI, while only 16.67% 
of women in Group 2 (No Follow-Up) gained weight within recommended ranges 
(p=0.453). No significant difference was found in mode of delivery between groups (p = 
0.165); however, it is worth noting that nearly 40% of those in the follow-up group 





























Infant outcome results are exhibited in Table 5. In addition, a box plot of lowest 
infant blood glucose levels and a bar graph demonstrating presence of hypoglycemia (BG 
<30 mg/dL), between groups, can be viewed in Figures 4 and 5.  
 
Table 5. Infant Outcomes 





 No. Mean SD No. Mean SD P-value 
Gestational Age (weeks) 27 38.8 1.4 14 38.6 1.3 0.349 
Birth Weight (grams) 27 3523 471.1 14 3315 277.5 0.187 
Lowest BG (mg/dL) 26 42.8 14.5 12 49.4 17.1 0.131 
APGAR Score (60 second) 27 7.3 2.2 12 8.1 1.2 0.208 
APGAR Score (10 minute) 27 8.3 1.9 12 8.8 0.8 0.723 
 No. Proportion % No. Proportion % P-value 
Presence of Hypoglycemia 
     Yes 




















Weight Appropriate for Age 
   Yes 





















   Yes 




















NICU Staff Present 
   Yes 





















   Yes 





















   Yes 





















   Yes 





























Mean gestational age (GA) was similar between groups, at 38.8 weeks for those 
in Group 1 and 38.6 weeks for infants in Group 2 (p=0.349). Mean birth weight between 
groups was also similar, with averages of 3,523 grams for infants in Group 1 and 3,315 
grams for infants in Group 2 (p=0.187). Although not statistically significant, 100% of 
infants in Group 2 had birth weights appropriate for their age, while this was only true for 
88.9% of infants in Group 1 (p=0.539).  
 When looking at average lowest blood glucose (Figure 4), differences were not 
significant between groups (p=0.131), but there were 4 occurrences of infant 
hypoglycemia (BG <30 mg/dL) in Group 1 (15.4%) and 1 incidence (8.3%) in Group 2. 
Need for intravenous, respiratory, and heart support was similar between groups (p=1.00) 
and aid of NICU staff was indicated in ~53% of births in both groups (p=0.740).  










































More women who attended group class also attended an individual follow-up 
appointment with a Certified Diabetes Educator than those who did not return for follow-
up, 67.3% verse 32.7%, respectively. Reason for lack of follow up is unknown and likely 
multifactorial; however, gravidity was significantly different between groups, with Group 
1 having an average of one previous pregnancy and those in Group 2 having an average 
of nearly three previous pregnancies (p=0.004). With this in mind, it may have been more 
difficult for women in Group 2 to schedule and attend an additional appointment, as they 
likely have more children to care for. Perception of risk may have also been 
compromised in this group resulting in less motivation to attend individual follow-up, 
since they have experienced a greater number of pregnancies in the past. Additionally, 
these women could have had GDM in past pregnancies and may have already received 
education in this area before. This could have contributed to higher confidence levels in 
blood glucose management during pregnancy and, thus, less motivation to return for 
follow-up.  
Additional explanations for lack of follow-up may include late diagnosis of GDM, 
delivery prior to scheduled follow-up appointment, overall perception that their case of 
GDM is mild or low-risk, and lack of interest or desire to attend a follow-up appointment.  
Maternal Outcomes 
Mean maternal weight gain was similar between groups (p=0.888); however, 
69.23% of women in Group 1 (Follow-Up) gained weight within recommended ranges 




individual follow-up (p=0.453). Although not statistically significant, this could suggest 
that individual follow-up with a Certified Diabetes Educator after group GDM class may 
aid expecting mothers in the management of weight gain throughout pregnancy.  
Mode of delivery between groups was not statistically significant (p=0.165); 
however, it is worth noting that nearly 40% of those in the follow-up group underwent 
caesarian sections compared to just 14.3% of women in Group 2. Reason for this is 
unknown; however, previous caesarian deliveries or increased severity of disease in the 
women who returned to individual follow-up may be influencing these results.  
The American Diabetes Association recommends that women aim for blood 
glucose levels less than 140 mg/dL one hour after a meal and less than 120 mg/dL two 
hours after a meal
1
. In this sample, no statistical significance was found in average 
maternal blood glucose between groups (p=0.670), as mean BG levels were 102 and 100 
for Group 1 and 2, respectively. Based on these results, it could be said that group 
gestational diabetes class alone helped this sample of women stay within recommended 
BG ranges; however, this information is limited to how well the patients monitored their 
blood glucose levels in between appointments. Additionally, for apparent ethical reasons, 
this study was designed without a true control group, as all women in this study received 
gestational diabetes education. It would be interesting to compare these outcomes to 
those of women with no specific gestational diabetes education at all.  
Infant Outcomes 
While mean gestational age (GA) and birth weight were similar between groups 
(p=0.349 and p=0.187, respectively), infants in Group 1 had two instances of 




infants born at weights appropriate for GA, 100% of infants in Group 2 were born at 
appropriate weights compared to 88.9% of infants in Group 1; this finding, however, was 
not statistically significant (p=0.539).  
 Between groups, no significant differences were found in average lowest blood 
glucose (p=0.131). Group 1 did have more instances of infant hypoglycemia, at 15.4% 
compared to 8.3% in Group 2, though not statistically significant (p=0.643). Need for 
intravenous, respiratory, and heart support was similar between groups (p=1.00) and aid 
of NICU staff was indicated in about 53% of births in both groups (p=0.740).  
Reasons behind these findings are unclear, but one could postulate that women 
who return for individual follow-up may be followed more closely by their physician due 
to higher risk, and therefore, are more likely to return to follow-up with their CDE. 
Number of previous pregnancies could also influence these results. As discussed earlier, 
gravidity of women in Group 2 is significantly higher than the average gravidity of Group 
1. Women who did not attend follow-up may have had GDM and education in previous 
pregnancies, making them more proficient in the management of their BG levels 
throughout pregnancy.  
Limitations 
Limitations of this study include its retrospective design, relatively small sample 
sizes, and lack of a true control group. The data obtained for this study was limited to 
what was documented in the electronic medical record and sample size was determined 
based on the number of women who attended group GDM class during the pre-
determined, specified time period of this study (July 2014-January 2015). Since it is not 




study received at least some gestational diabetes education, meaning this study had no 


























In conclusion, individual follow-up rate after group gestational diabetes class was 
67.3%, leaving 32.7% without follow-up with a Certified Diabetes Educator at Nebraska 
Medicine’s Diabetes Center. Lack of follow-up is likely related to number of previous 
pregnancies, as gravidity in the follow-up group was significantly lower when compared 
to the group without individual follow-up.  
No significant differences in maternal and fetal outcomes were identified between 
groups, perhaps related to limited sample size. Overall, findings from this study indicate 
that group GDM class held at Nebraska Medicine’s Diabetes Center, on its own, 
successfully communicates information to expecting mothers with gestational diabetes to 
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